Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.25
Bid: 19.50
Ask: 21.00
Change: -0.25 (-1.22%)
Spread: 1.50 (7.692%)
Open: 20.50
High: 20.50
Low: 20.25
Prev. Close: 20.50
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IO#8 and Debt Update

26 Jun 2020 07:00

RNS Number : 1497R
Iofina PLC
26 June 2020
 

 

26 June 2020

 

Iofina Plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

IO#8 and Debt Update

 

Iofina, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, is pleased to announce that operations at its newest iodine plant, IO#8, have recommenced. The Company is also pleased to provide an update on its debt refinancing.

 

IO#8 Update

Last month, Iofina reported that its newest iodine plant, IO#8, was idled due to shut-in wells, as a direct consequence of the significant drop in U.S. oil prices. The Company is now pleased to report that it has restarted operations at IO#8 as a large number of wells supplying brine to the plant have now been reopened. Iofina Resources, a subsidiary of the Company, is working with its partners to maintain a steady supply of iodide rich brine to IO#8 and explore options to further increase the flow of brine to the plant. All other IOsorb® plants are receiving brine water as normal and producing iodine within expected rates.

 

Debt Update

The Company continues to make significant progress towards refinancing its debt and can confirm that it is in the final stages of negotiation with a new primary lender based in the United States. However, there have been significant delays experienced in the refinancing process, principally due to COVID-19 and the resulting additional work for lenders in the United States to satisfy borrower demand under the US Government's Small Business Administration's Paycheck Protection Program ("PPP") which is part of the US Coronavirus Aid Relief and Economic Security Act.

 

The Company is pleased to report that Stena Investments S.à.r.l. ("Stena"), the Company's senior secured lender, has agreed, in principle, to extend the current repayment deadline for an additional two months from 1 July 2020 to 1 September 2020 in order to facilitate completion of this refinancing (the "Extension"). Contracts pertaining to the Extension are in the course of being finalised and are expected to be executed prior to 1 July 2020. The terms of the Extension will require an aggregate payment of approximately USD3.05m to Stena which represents all accrued and unpaid interest and fees owing to Stena on 1 July 2020, and a partial payment of 15% of the aggregate outstanding principal amount owned to Stena. Outstanding sums not repaid will maintain the same interest rate of 7.5% over the extension period.

 

The Company's junior secured lender, Southern Rock Insurance Company Limited ("SRICL"), has not agreed to this same extension at this time. The Board will try to continue to work with SRICL during the period to 1 July and, if necessary, during the grace period of 21 days provided for in the current loan documentation. The Company will use cash on hand for payments due to the debt holders, and intends to pay in aggregate approximately USD294k to SRICL which represents all interest and fees due on 1 July 2020 and a partial payment of 15% of the aggregate outstanding principal amount owed to SRICL.

 

The Directors remain confident that the Company will complete this loan refinancing within the Extension.

 

Commenting, President and CEO of Iofina Dr. Tom Becker, stated: "It's a great boost to Iofina that most wells supplying IO#8 have already reopened, which has allowed us to restart iodine extraction at this site much earlier than originally anticipated. The Company's other plants have remained operational as normal and have been producing iodine within expected rates during the unfortunate global COVID-19 pandemic. We will now continue to maximize iodine production across all five of our IOsorb® plants in Oklahoma.

 

"We are grateful to Stena, our senior lender, for agreeing to the terms of the two month extension to the repayment deadline. We are extremely pleased with the progress that we have made despite the delays to the process caused by the COVID-19 outbreak and we are confident that we can complete the refinancing within this extended timeframe."

 

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Matthew Radley (corporate finance)

Camille Gochez (ECM)

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Charles Goodwin/Joe Burgess

Yellow Jersey PR Limited

Tel: +44 (0)20 3004 9512

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated Company that specialises in the production of Iodine and the manufacturing of specialty chemical products. As the second largest producer of iodine in North America, it comprises three USA entities; Iofina Resources, Iofina Chemical and IofinaEX.

 

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina currently operates five producing IOsorb® plants in Oklahoma and is consistently using technology and innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen speciality chemicals derived from raw iodine, as well as non-iodine based products for over 35 years.

 

IofinaEX

Iofina's newest subsidiary, IofinaEX, is fully licensed to process hemp in the state of Kentucky and is exploring the isolation of specialty chemical products from hemp, a rapidly expanding market.

 

www.iofina.com

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFAMMTMTJTTTM
Date   Source Headline
16th Apr 20247:00 amRNSQ1 2024 Corporate Update
17th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSQ4 2023 Corporate Update
30th Nov 20237:00 amRNSIO#9 Update
20th Oct 20237:00 amRNSSigned Agreement for IO#10 and Q3 2023 Update
11th Sep 20237:00 amRNSInterim Results
25th Aug 20235:00 pmRNSHolding(s) in Company
24th Jul 20235:00 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSH1 Update and Updated Loan Facilities
14th Jun 20232:00 pmRNSResult of AGM
14th Jun 20237:00 amRNSIO#9 Iodine Plant Operating
9th May 20237:00 amRNSNotice of AGM
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20234:45 pmRNSHolding(s) in Company
28th Apr 20237:00 amRNSGrant of Share Options
25th Apr 20237:00 amRNS2022 FULL YEAR RESULTS
12th Apr 20237:00 amRNSProduction Update
20th Feb 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Update
9th Jan 20237:00 amRNSMarket Update
28th Dec 20222:34 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSIofina Chemical Awarded ISO Certification
21st Nov 20227:00 amRNSChange of Adviser
28th Oct 20227:00 amRNSFinalised Terms for IO9 & Q3 Production Update
26th Sep 202211:06 amRNSSecond Price Monitoring Extn
26th Sep 202211:00 amRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSInterim Results
8th Jul 20227:00 amRNSAdditional Loan Facilities and H1 Update
5th Jul 20228:54 amRNSHolding(s) in Company
22nd Jun 20222:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSAppointment of Chrystal Capital Partners LLP
27th May 20227:00 amRNSNotice of AGM
26th May 20224:15 pmRNSHolding(s) in Company
26th May 20222:15 pmRNSHolding(s) in Company
24th May 20226:15 pmRNSHolding(s) in Company
20th May 20227:10 amRNSInvestor Presentation
18th May 20227:00 amRNSHolding(s) in Company
9th May 20227:00 amRNSFinal Results
5th May 20227:00 amRNSHolding(s) in Company
28th Apr 20228:38 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSQ1 2022 and IO#9 Update
8th Apr 20221:07 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSHolding(s) in Company
14th Mar 20227:00 amRNSDirector/PDMR Shareholding
11th Mar 20227:00 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSGrant of Share Options
8th Mar 20228:51 amRNSHolding(s) in Company
17th Jan 20229:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.